185 related articles for article (PubMed ID: 10360479)
1. Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats.
Saini M; Bellinzona M; Meyer F; Cali G; Samii M
J Neurooncol; 1999 Mar; 42(1):59-67. PubMed ID: 10360479
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 9L glioma model of the Wistar rat.
Stojiljkovic M; Piperski V; Dacevic M; Rakic L; Ruzdijic S; Kanazir S
J Neurooncol; 2003 May; 63(1):1-7. PubMed ID: 12814248
[TBL] [Abstract][Full Text] [Related]
3. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
4. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
6. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.
Barth RF
J Neurooncol; 1998 Jan; 36(1):91-102. PubMed ID: 9525831
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
8. Growth of precultured human glioma specimens in nude rat brain.
Engebraaten O; Hjortland GO; Hirschberg H; Fodstad O
J Neurosurg; 1999 Jan; 90(1):125-32. PubMed ID: 10413165
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12-based immunotherapy against rat 9L glioma.
Jean WC; Spellman SR; Wallenfriedman MA; Hall WA; Low WC
Neurosurgery; 1998 Apr; 42(4):850-6; discussion 856-7. PubMed ID: 9574650
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic activity of endostatin inhibits C6 glioma growth.
Peroulis I; Jonas N; Saleh M
Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365
[TBL] [Abstract][Full Text] [Related]
11. Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.
Cretu A; Fotos JS; Little BW; Galileo DS
Clin Exp Metastasis; 2005; 22(3):225-36. PubMed ID: 16158250
[TBL] [Abstract][Full Text] [Related]
12. Boswellic acids inhibit glioma growth: a new treatment option?
Winking M; Sarikaya S; Rahmanian A; Jödicke A; Böker DK
J Neurooncol; 2000; 46(2):97-103. PubMed ID: 10894362
[TBL] [Abstract][Full Text] [Related]
13. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
[TBL] [Abstract][Full Text] [Related]
14. Reduced tumorigenicity of rat glioma cells in the brain when mediated by hygromycin phosphotransferase.
Hormigo A; Friedlander DR; Brittis PA; Zagzag D; Grumet M
J Neurosurg; 2001 Apr; 94(4):596-604. PubMed ID: 11302658
[TBL] [Abstract][Full Text] [Related]
15. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
Mathieu D; Lecomte R; Tsanaclis AM; Larouche A; Fortin D
Can J Neurol Sci; 2007 Aug; 34(3):296-306. PubMed ID: 17803026
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.
Yang WQ; Lun X; Palmer CA; Wilcox ME; Muzik H; Shi ZQ; Dyck R; Coffey M; Thompson B; Hamilton M; Nishikawa SG; Brasher PM; Fonseca K; George D; Rewcastle NB; Johnston RN; Stewart D; Lee PW; Senger DL; Forsyth PA
Clin Cancer Res; 2004 Dec; 10(24):8561-76. PubMed ID: 15623640
[TBL] [Abstract][Full Text] [Related]
17. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
[TBL] [Abstract][Full Text] [Related]
18. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
Barth RF; Kaur B
J Neurooncol; 2009 Sep; 94(3):299-312. PubMed ID: 19381449
[TBL] [Abstract][Full Text] [Related]
19. A model for intratumoural chemotherapy in the rat brain.
Saini M; Roser F; Samii M; Bellinzona M
Acta Neurochir (Wien); 2004 Jul; 146(7):731-4. PubMed ID: 15197617
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region.
Watanabe K; Sakamoto M; Somiya M; Amin MR; Kamitani H; Watanabe T
Neurol Res; 2002 Jul; 24(5):485-90. PubMed ID: 12117320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
